Angiotensin II treatment of vascular smooth muscle cells increased PYK2 tyrosine phosphorylation and kinase activity in a concentration- and time-dependent manner.
Angiotensin II activates the tyrosine kinase PYK2 in vascular smooth muscle cells via calcium- and PKC-dependent mechanisms, providing a potential link to downstream growth signaling.
Angiotensin II (Ang II) induces vascular smooth muscle cell (VSMC) growth by activating Gq-protein-coupled AT1 receptors, which leads to elevation of cytosolic Ca2+ (Ca2+i) and activation of protein kinase C (PKC) and mitogen-activated protein kinases. To assess the link between these Ang II-induced signaling events, we examined the effect of Ang II on the proline-rich tyrosine kinase (PYK2), previously found to be activated by a variety of stimuli that increase Ca2+i or activate PKC. PYK2 distribution was demonstrated in rat aortic tissue and in cultured VSMC by immunohistochemistry, revealing a cytosolic distribution distinct from smooth muscle alpha-actin, focal adhesion kinase, or paxillin. The involvement of PYK2 in Ang II signaling was measured by immunoprecipitation and immune complex kinase assays. Treatment of quiescent VSMC with Ang II resulted in a concentration- and time-dependent increase in PYK2 tyrosine phosphorylation and kinase activity in PYK2 immunoprecipitates. PYK2 phosphorylation was inhibited by AT1 receptor blockade and was attenuated by downregulation of PKC or the chelation of Ca2+i. Treatment with either phorbol ester or Ca2+ ionophore also increased PYK2 phosphorylation, suggesting that PKC activation and/or increased Ca2+i are both necessary and sufficient to activate PYK2. Activation of PYK2 by Ang II was also associated with increased PYK2-src complex formation, suggesting that PYK2 activation represents a potential link between Ang II-stimulated Ca2+i and PKC activation with downstream signaling events such as mitogen-activated protein kinase activation involved in the regulation of VSMC growth.
Sabri et al. (Mon,) reported a other. Angiotensin II was evaluated on PYK2 tyrosine phosphorylation and kinase activity. Angiotensin II treatment of vascular smooth muscle cells increased PYK2 tyrosine phosphorylation and kinase activity in a concentration- and time-dependent manner.